Aglaia BioMedical Ventures
Europe, Utrecht, The Netherlands, Bilthoven
Description
Aglaia is founded on the principle that the willingness to take risks on the very early stage ventures of today results in opportunities
Investor Profile
Aglaia BioMedical Ventures has backed more than 10 startups, with 0 new investments in the last 12 months alone. The firm has led 3 rounds, about 30% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Seed rounds (top funding stages).
- Majority of deals are located in The Netherlands, Switzerland, United States.
- Strong thematic focus on Biotechnology, Pharmaceutical, Health Care.
Stage Focus
- Series A (50%)
- Series B (30%)
- Seed (10%)
- Series Unknown (10%)
Country Focus
- The Netherlands (40%)
- Switzerland (30%)
- United States (30%)
Industry Focus
- Biotechnology
- Pharmaceutical
- Health Care
- Therapeutics
- Information Technology
- Medical
- Oncology
- Life Science
- 3d Technology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
